Detalles de la búsqueda
1.
Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial.
Health Qual Life Outcomes
; 17(1): 173, 2019 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31729982
2.
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Oncol
; 18(3): 297-311, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28139405
3.
Use of CYP3Ai and impact on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine in the VIALE-A study.
Am J Hematol
; 97(11): E422-E425, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36053878
4.
Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial.
JAMA Oncol
; 4(5): 652-659, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29522138
Resultados
1 -
4
de 4
1
Próxima >
>>